Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada. more
Time Frame | VNRX | Sector | S&P500 |
---|---|---|---|
1-Week Return | -6.78% | -2.06% | -0.55% |
1-Month Return | -8.2% | -1.92% | 2.72% |
3-Month Return | -0.67% | -10.4% | 7.66% |
6-Month Return | -8.2% | -4.6% | 10.15% |
1-Year Return | -20.28% | 4.06% | 27.53% |
3-Year Return | -81.97% | 1.94% | 32.31% |
5-Year Return | -86.14% | 36.48% | 89.2% |
10-Year Return | -84.26% | 97.46% | 194.59% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 17.10K | 13.43K | 90.03K | 306.39K | 775.30K | [{"date":"2019-12-31","value":2.21,"profit":true},{"date":"2020-12-31","value":1.73,"profit":true},{"date":"2021-12-31","value":11.61,"profit":true},{"date":"2022-12-31","value":39.52,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | - | - | - | 1.19M | 1.41M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":84.19,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 17.10K | 13.43K | 90.03K | (882.03K) | 775.30K | [{"date":"2019-12-31","value":2.21,"profit":true},{"date":"2020-12-31","value":1.73,"profit":true},{"date":"2021-12-31","value":11.61,"profit":true},{"date":"2022-12-31","value":-113.77,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 100.00% | 100.00% | 100.00% | (287.88%) | 100.00% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-287.88,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 15.90M | 20.63M | 26.90M | 30.86M | 36.76M | [{"date":"2019-12-31","value":43.26,"profit":true},{"date":"2020-12-31","value":56.1,"profit":true},{"date":"2021-12-31","value":73.17,"profit":true},{"date":"2022-12-31","value":83.94,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (16.04M) | (21.25M) | (28.33M) | (31.78M) | (35.99M) | [{"date":"2019-12-31","value":-1604292400,"profit":false},{"date":"2020-12-31","value":-2124781500,"profit":false},{"date":"2021-12-31","value":-2833307900,"profit":false},{"date":"2022-12-31","value":-3178007200,"profit":false},{"date":"2023-12-31","value":-3598769500,"profit":false}] |
Total Non-Operating Income/Expense | (70.34K) | 768.22K | 1.19M | 1.13M | 241.91K | [{"date":"2019-12-31","value":-5.91,"profit":false},{"date":"2020-12-31","value":64.54,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.26,"profit":true},{"date":"2023-12-31","value":20.33,"profit":true}] |
Pre-Tax Income | (16.10M) | (20.40M) | (26.99M) | (30.60M) | (35.68M) | [{"date":"2019-12-31","value":-1609905500,"profit":false},{"date":"2020-12-31","value":-2039929400,"profit":false},{"date":"2021-12-31","value":-2698978100,"profit":false},{"date":"2022-12-31","value":-3059846900,"profit":false},{"date":"2023-12-31","value":-3567707400,"profit":false}] |
Income Taxes | (70.39K) | 82.62K | (19.31K) | (329.68K) | (357.99K) | [{"date":"2019-12-31","value":-85.19,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-23.38,"profit":false},{"date":"2022-12-31","value":-399.03,"profit":false},{"date":"2023-12-31","value":-433.3,"profit":false}] |
Income After Taxes | (16.03M) | (20.48M) | (26.97M) | (30.27M) | (35.32M) | [{"date":"2019-12-31","value":-1602867000,"profit":false},{"date":"2020-12-31","value":-2048191400,"profit":false},{"date":"2021-12-31","value":-2697046800,"profit":false},{"date":"2022-12-31","value":-3026879300,"profit":false},{"date":"2023-12-31","value":-3531908000,"profit":false}] |
Income From Continuous Operations | (16.10M) | (20.40M) | (26.99M) | (31.78M) | (34.21M) | [{"date":"2019-12-31","value":-1609905500,"profit":false},{"date":"2020-12-31","value":-2039929400,"profit":false},{"date":"2021-12-31","value":-2698978100,"profit":false},{"date":"2022-12-31","value":-3178007200,"profit":false},{"date":"2023-12-31","value":-3421356200,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (16.03M) | (20.48M) | (26.97M) | (30.27M) | (35.32M) | [{"date":"2019-12-31","value":-1602867000,"profit":false},{"date":"2020-12-31","value":-2048191400,"profit":false},{"date":"2021-12-31","value":-2697046800,"profit":false},{"date":"2022-12-31","value":-3026879300,"profit":false},{"date":"2023-12-31","value":-3531907800,"profit":false}] |
EPS (Diluted) | (0.41) | (0.45) | (0.50) | (0.55) | (0.51) | [{"date":"2019-12-31","value":-41,"profit":false},{"date":"2020-12-31","value":-45,"profit":false},{"date":"2021-12-31","value":-50,"profit":false},{"date":"2022-12-31","value":-55,"profit":false},{"date":"2023-12-31","value":-51,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
VNRX | |
---|---|
Cash Ratio | 0.18 |
Current Ratio | 0.22 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
VNRX | |
---|---|
ROA (LTM) | -100.82% |
ROE (LTM) | -730.06% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
VNRX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 2.79 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -1.70 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
VNRX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 57.88 |
P/B | 38.44 |
Price/FCF | NM |
EV/R | 46.72 |
EV/Ebitda | NM |
PEG | NM |
Volitionrx Ltd (VNRX) share price today is $0.639
Yes, Indians can buy shares of Volitionrx Ltd (VNRX) on Vested. To buy Volitionrx Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VNRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Volitionrx Ltd (VNRX) via the Vested app. You can start investing in Volitionrx Ltd (VNRX) with a minimum investment of $1.
You can invest in shares of Volitionrx Ltd (VNRX) via Vested in three simple steps:
The 52-week high price of Volitionrx Ltd (VNRX) is $1.23. The 52-week low price of Volitionrx Ltd (VNRX) is $0.43.
The price-to-earnings (P/E) ratio of Volitionrx Ltd (VNRX) is
The price-to-book (P/B) ratio of Volitionrx Ltd (VNRX) is 38.44
The dividend yield of Volitionrx Ltd (VNRX) is 0.00%
The market capitalization of Volitionrx Ltd (VNRX) is $56.53M
The stock symbol (or ticker) of Volitionrx Ltd is VNRX